Skip to content

Type: White Papers

Improving Equity in Oncology Clinical Trials: Challenges and Strategies for Setting Diversity Enrollment Goals

Maximizing Data from Academic-Led Studies for Regulatory Decision-Making

Incorporating Pragmatic Elements in Study Designs to Enhance Oncology Randomized Clinical Trials

Interpreting Data from Dose-Finding Studies in Early Phase Oncology Trials to Determine the Optimal Dose

Supporting The Application Of Computational Pathology In Oncology

Accelerating The Development Of Engineered Cellular Therapies

Accelerating Investigation of New Therapies in Earlier Metastatic Treatment Settings

2022 Annual Meeting: Impact of the COVID-19 Pandemic Mitigation Strategies on Cancer Clinical Trials

2022 Annual Meeting: Supporting a Patient-Centric Approach to Dose Optimization in Oncology: The Essential Role of Patient-Reported Outcomes (PROs)

Circulating Tumor DNA in Development of Therapies for Cancer: An Evidentiary Roadmap to an Early Endpoint for Regulatory Decision-Making